| Literature DB >> 34222775 |
Rebecca Pedley1, Linda E Dean2, Ernest Choy3, Karl Gaffney4, Tanzeel Ijaz5, Lesley Kay6, Karina Lovell1, Christine Molloy1, Kathryn Martin2, Jonathan Packham7,8, Stefan Siebert9, Raj Sengupta10,11, Gary J Macfarlane2, Rosemary J Hollick2.
Abstract
OBJECTIVE: The aim was to assess the feasibility and acceptability of a telephone-based cognitive behaviour therapy (tCBT) intervention for individuals with axial SpA (axSpA), with and without co-morbid FM, and to measure the change in patient-reported health outcomes.Entities:
Keywords: axial SpA; feasibility; fibromyalgia; telephone-based cognitive behavioural therapy
Year: 2020 PMID: 34222775 PMCID: PMC8248414 DOI: 10.1093/rap/rkaa063
Source DB: PubMed Journal: Rheumatol Adv Pract ISSN: 2514-1775
Definitions of the seven constructs of the theoretical framework of acceptability (reproduced from Sekhon et al. [15])
| Theoretical Framework of acceptability (TFA) | Definition |
|---|---|
| Ethicality | The extent to which the intervention has a good fit with an individual’s value system |
| Affective attitude | How an individual feels about the intervention, after taking part |
| Burden | The amount of effort that was required to participate in the intervention |
| Opportunity costs | The benefits, profits or values that were given up to engage in the intervention |
| Perceived effectiveness | Experienced effectiveness: the extent to which the intervention is perceived to have achieved its intended purpose |
| Self-efficacy | The participant's confidence that they can perform the behaviour(s) required to participate in the intervention |
| Intervention coherence | The extent to which the participant understands the intervention and how it works |
Baseline descriptors of those offered CBT and who attended at least one session (n = 28)
| Baseline factors | Frequency | Percentage/median (IQR) | |
|---|---|---|---|
| Age | 28 | 59 (49, 70) | |
| Gender | Female | 11 | 40.7 |
| Male | 16 | 59.3 | |
| Education | Secondary school | 6 | 24.0 |
| Apprenticeship/college | 10 | 40.0 | |
| University/further education | 9 | 36.0 | |
| Employment | Full-time/unpaid | 9 | 34.6 |
| Part-time | 5 | 19.2 | |
| Retired | 9 | 34.6 | |
| Retired/unemployed (owing to health) | 3 | 11.5 | |
| Prescribed a biologic DMARD? | Yes | 13 | 48.2 |
| No | 14 | 51.8 | |
| Disease duration | Years | 25 | 36 (12, 48) |
| Physical activity | Minutes of walking/day | 25 | 60 (25, 120) |
| Days with moderate physical activity/week | 25 | 4 (2, 7) | |
| Days with vigorous physical activity/week | 26 | 2 (0, 4) | |
| Spinal pain VAS | 0 (best)–10 (worst) | 26 | 5.0 (2.0, 7.8) |
| Disease activity | BASDAI: 0 (best)–10 (worst) | 26 | 5.6 (2.4, 7.0) |
| Functional impairment | BASFI: 0 (best)–10 (worst) | 25 | 5.1 (2.1, 7.2) |
| Quality of life | ASQoL: 0 (best)–18 (worst) | 23 | 8.0 (3.0, 11.0) |
| Fatigue | CFS: 0 (best)–11 (worst) | 24 | 3.5 (1.5, 7.0) |
| Sleep disturbance | Jenkins: 0 (best)–20 (worst) | 24 | 10.5 (5.5, 16.0) |
| Anxiety | HADS: 0 (best)–21 (worst) | 24 | 9.0 (5.0, 12.5) |
| Depression | HADS: 0 (best)–21 (worst) | 24 | 4.0 (2.5, 8.0) |
| Widespread pain index | 0 (best)–19 (worst) | 21 | 6.0 (2.0, 11.0) |
| Symptom severity score | 0 (best)–12 (worst) | 25 | 6.0 (4.0, 10.0) |
Years from symptom onset to screening visit.
ASQoL: AS Quality of Life Index; CBT: cognitive behavioural therapy; CFS: Chalder Fatigue Scale; HADS: Hospital Anxiety and Depression Scale; IQR: inter-quartile range; VAS: visual analog scale.
Patient-reported outcome change among those offered CBT and attending at least one session (n = 22)
| Frequency | Percentage | |
|---|---|---|
| Improved | 13 | 61.9 |
| Same | 3 | 14.3 |
| Worse | 5 | 23.8 |
| Spinal pain VAS | 20 | −1.0 (−1.5, 0.0) |
| Disease activity (BASDAI) | 20 | −0.9 (−1.5, 0.2) |
| Functional impairment (BASFI) | 19 | −0.3 (−0.7, 0.1) |
| Quality of life (ASQoL) | 15 | 0.0 (−2.0, 1.0) |
| Fatigue (CFS) | 18 | −1.0 (−2.0, 0.0) |
| Sleep disturbance (Jenkins) | 18 | −1.0 (−3.0, 1.0) |
| Anxiety (HADS) | 18 | −1.0 (−3.0, 1.0) |
| Depression (HADS) | 18 | 0.0 (−2.0, 1.0) |
| Widespread pain index | 13 | −1.0 (−2.0, 0.0) |
| Symptom severity score | 20 | −0.5 (−1.5, 1.0) |
ASQoL: AS Quality of Life Index; CFS: Chalder Fatigue Scale; HADS: Hospital Anxiety and Depression Scale; IQR: inter-quartile range; VAS: visual analogue scale.